Vitamin D Supplementation and Prevention of Type 2 Diabetes. (Record no. 4409)

MARC details
000 -LEADER
fixed length control field 03647nam a22003977a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190621s20192019 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0028-4793
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1056/NEJMoa1900906 [doi]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 31173679
245 ## - TITLE STATEMENT
Title Vitamin D Supplementation and Prevention of Type 2 Diabetes.
251 ## - Source
Source New England Journal of Medicine. 2019 Jun 07
252 ## - Abbreviated Source
Abbreviated source N Engl J Med. 2019 Jun 07
253 ## - Journal Name
Journal name The New England journal of medicine
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2019
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2019
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status aheadofprint
266 ## - Date added to catalog
Date added to catalog 2019-06-21
501 ## - WITH NOTE
Local holdings Available online from MWHC library: 1993 - present, Available in print through MWHC library: 1980 - present
520 ## - SUMMARY, ETC.
Abstract BACKGROUND: Observational studies support an association between a low blood 25-hydroxyvitamin D level and the risk of type 2 diabetes. However, whether vitamin D supplementation lowers the risk of diabetes is unknown.
520 ## - SUMMARY, ETC.
Abstract CONCLUSIONS: Among persons at high risk for type 2 diabetes not selected for vitamin D insufficiency, vitamin D<sub>3</sub> supplementation at a dose of 4000 IU per day did not result in a significantly lower risk of diabetes than placebo. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; D2d ClinicalTrials.gov number, NCT01942694.).
520 ## - SUMMARY, ETC.
Abstract Copyright (c) 2019 Massachusetts Medical Society.
520 ## - SUMMARY, ETC.
Abstract METHODS: We randomly assigned adults who met at least two of three glycemic criteria for prediabetes (fasting plasma glucose level, 100 to 125 mg per deciliter; plasma glucose level 2 hours after a 75-g oral glucose load, 140 to 199 mg per deciliter; and glycated hemoglobin level, 5.7 to 6.4%) and no diagnostic criteria for diabetes to receive 4000 IU per day of vitamin D<sub>3</sub> or placebo, regardless of the baseline serum 25-hydroxyvitamin D level. The primary outcome in this time-to-event analysis was new-onset diabetes, and the trial design was event-driven, with a target number of diabetes events of 508.
520 ## - SUMMARY, ETC.
Abstract RESULTS: A total of 2423 participants underwent randomization (1211 to the vitamin D group and 1212 to the placebo group). By month 24, the mean serum 25-hydroxyvitamin D level in the vitamin D group was 54.3 ng per milliliter (from 27.7 ng per milliliter at baseline), as compared with 28.8 ng per milliliter in the placebo group (from 28.2 ng per milliliter at baseline). After a median follow-up of 2.5 years, the primary outcome of diabetes occurred in 293 participants in the vitamin D group and 323 in the placebo group (9.39 and 10.66 events per 100 person-years, respectively). The hazard ratio for vitamin D as compared with placebo was 0.88 (0.95% confidence interval, 0.75 to 1.04; P = 0.12). The incidence of adverse events did not differ significantly between the two groups.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Good Samaritan Hospital
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Health Research Institute
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Aroda, Vanita R
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Ghazi, Adline
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Park, Jean
790 ## - Authors
All authors Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, D2d Research Group, Dawson-Hughes B, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, Knowler WC, LeBlanc ES, Lewis MR, Liao E, Neff LM, Nelson J, O'Neil P, Park J, Peters A, Phillips LS, Pittas AG, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Sheehan P, Staten M, Vickery EM, Ware JH
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1056/NEJMoa1900906">https://dx.doi.org/10.1056/NEJMoa1900906</a>
Public note https://dx.doi.org/10.1056/NEJMoa1900906
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 06/21/2019   31173679 31173679 06/21/2019 06/21/2019 Journal Article

Powered by Koha